Answers are grounded in this paper and cite their sources.
The different COVID-19 vaccines currently available appear to have distinct reactogenicity profiles, dependent on the vaccine technology employed. Awareness of these differences may allow targeted recommendations for specific populations. Greater standardization of methods for adverse event reporting will aid future research in this field.
No takes yet. Share an insight, caveat, or question.
Sutton et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: